Dr. Paul T. Finger has been named one of America’s top doctors in 2016. Castle Connolly’s top doctors are nominated by their peers through an extensive survey process of thousands of American physicians. Each year, Castle Connolly receives nearly 100,000 nominations through this process. The organization’s research team screens medical education, training, board certifications, hospital [..] Read More…
As a parent, you should trust your instincts. If you sense something might be wrong, you’re probably right. Ignoring your gut feeling could lead to tragic consequences. Timely diagnosis is key to treating eye cancer. When caught early, doctors can often remove the tumor and preserve sight. But waiting too long can lead to loss [..] Read More…
A new study suggests patients diagnosed with uveal melanoma could benefit from immunotherapies that harness the body’s own anti-tumor T-cell populations. Uveal melanoma is a cancer of the eye involving the iris, the muscle surrounding the lens, or the choroid – a vascular layer with connective tissue between the retina and the sclera. It is a [..] Read More…
In addition to his daily work treating his own patients at the NYECC, Dr. Finger is committed to advancing research that will benefit people diagnosed with eye cancer around the world. In that spirit, Dr. Finger is working with the Ophthalmic Oncology Task Force to create a database on vitreoretinal lymphoma that will ultimately lead [..] Read More…
Your smartphone camera flash can detect a rare eye cancer, potentially saving a child’s life. That was the case for an Arizona mother who inadvertently detected retinoblastoma in her young son after using a flash phone camera to take pictures of him. Andrea Temarantz noticed a white glow in the left eye of her son [..] Read More…
A drug thrust into the limelight by Jimmy Carter shows promise for treating melanoma of the eyelid. Keytruda (pembrolizumab) gained FDA approval for limited treatment of metastatic melanomas in late 2014. The agency gave its blessing for front-line treatment in patients with unresectable or metastatic melanoma on Jan. 7 of this year. The drug is [..] Read More…
Прочитайте эту статью на русском языке Dr. Finger recently published a scholarly article in the Russian Ophthalmological Journal. The paper chronicles the successful diagnosis and treatment of a 9-month-old girl. The case was particularly significant because Dr. Finger was able to diagnose and cure the girl through essentially non-invasive treatments. The diagnosis was made clinically [..] Read More…
Dr. Paul Finger has developed a memory tool to help ophthalmologists identify and catch eye cancers. This simple but effective mnemonic serves as a guide to aide in knowing when to send a patient to an eye cancer specialist. To effectively diagnose Choroidal Melanoma, ophthalmologists just need to remember “MOST.” Dr. Tero Kivela presented Dr. [..] Read More…
The Eye Cancer Foundation (ECF) is pleased to announce funding to support retinoblastoma education fellowships for candidates from unserved and underserved countries. These fellowships may be from the ECF, Princess Margaret Cancer Center, and/or the International Council of Ophthalmology.
The following article by Dr. Finger was originally published on Retinal Physician. Find it here. Benjamin Franklin once wrote, “an ounce of prevention is worth a pound of cure.”1 Although he was referring to fire prevention, this adage also applies to radiation maculopathy. Over the years, I have relentlessly sought ways to decrease therapeutic radiation [..] Read More…
"Very well treated by Dr. Finger. He explained everything I needed to know about my issue with detail and attention, putting me at ease and giving me confidence to handle this problem for the rest of my life.”
– N.N.
